- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00417469
A Study to Compare Subject Comfort During and After Injections With the Study Products and the Safety of the Non-FDA Approved Product for the Correction of Nasolabial Folds (NLFs)
March 4, 2015 updated by: Genzyme, a Sanofi Company
A Single-Blind, Randomized, Single-Center Evaluation of Procedural and Post Procedural Pain Experienced With Injections of NADG With Lidocaine Injectable Gel as Compared to Captique® Injectable Gel in Subjects Undergoing Cutaneous Correction of Nasolabial Folds
The purpose of this research study is to compare subject comfort during and after injection with NADGL and Captique® Injectable Gel, in the nasolabial folds.
Captique® is an FDA-approved product without lidocaine and is manufactured by Genzyme Biosurgery (Ridgefield, NJ).
NADGL is a new product (not FDA approved) with lidocaine and is also manufactured by Genzyme Biosurgery.
We do not know which of these treatments results in less pain during and after injection.
The safety of NADGL is also being studied.
Study Overview
Detailed Description
45 subjects are planned; a portion of these subjects will have skin of color
Study Type
Interventional
Enrollment
45
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35205
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Description
Inclusion Criteria:
- bilateral nasolabial folds with severity score of 3 or 4 on the 6 point scale.
Exclusion Criteria:
- pregnant/lactating women
- subjects who have an allergy to lidocaine or other amide-type anesthetics
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
To evaluate the pain experienced during and after the injection procedure for NADGL as compared to Captique® Injectable Gel in subjects undergoing cutaneous correction of nasolabial folds (NLFs).
|
Secondary Outcome Measures
Outcome Measure |
---|
To evaluate the safety of NADGL.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2007
Study Completion (Actual)
February 1, 2007
Study Registration Dates
First Submitted
December 28, 2006
First Submitted That Met QC Criteria
December 29, 2006
First Posted (Estimate)
January 1, 2007
Study Record Updates
Last Update Posted (Estimate)
March 5, 2015
Last Update Submitted That Met QC Criteria
March 4, 2015
Last Verified
March 1, 2015
More Information
Terms related to this study
Other Study ID Numbers
- NADGL00106
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Facial Wrinkles
-
The Plastic Surgery FoundationCompletedFacial Photo Damage | Periocular Fine Wrinkles | Perioral Fine WrinklesUnited States
-
Genzyme, a Sanofi CompanyInamed AestheticsCompleted
-
DeYi Aesthetic Medical ClinicNot yet recruiting
-
PollogenUnknownFacial WrinklesUnited States
-
ConturaCompletedFacial WrinklesUnited States
-
YMD Eye and FaceCompletedFacial WrinklesUnited States
-
Merz North America, Inc.CompletedFacial WrinklesUnited States
-
Merz North America, Inc.CompletedFacial WrinklesUnited States
-
Catalysis SLCompleted
-
Phytotox SAWithdrawn